Low-level Viremia in Treated HIV-1 Infected Patients: Advances and Challenges

被引:8
|
作者
Bai, Ruojing [1 ]
Lv, Shiyun [2 ]
Wu, Hao [1 ]
Dai, Lili [2 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing 100069, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Travel Clin, Beijing, Peoples R China
基金
北京市自然科学基金;
关键词
Antiretroviral therapy; HIV-1; infection; low-level viremia; virological failure; reservoir; clinical management; ANTIRETROVIRAL DRUG-RESISTANCE; IMMUNODEFICIENCY-VIRUS TYPE-1; PERSISTENT HIV-1 REPLICATION; TO-CHILD TRANSMISSION; IMMUNE RECONSTITUTION; VIROLOGICAL FAILURE; TRANSIENT VIREMIA; INFECTED PATIENTS; NO EVIDENCE; RNA LEVELS;
D O I
10.2174/1570162X20666220216102943
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antiretroviral therapy (ART) can effectively suppress HIV-1 replication, improving quality of life and restoring the lifespan of persons living with HIV (PLWH) to near-normal levels. However, after standardized ART, a low level of HIV-1 RNA, i.e., low-level viremia (LLV), may still be identified in 3% to 10% of the patients. LLV is capable of impacting the immunological and clinical outcomes of patients and serves as a risk factor for transmission. The underlying mechanism of LLV is not yet certain, and the effects of LLV on patient outcomes remain under evaluation. Understanding LLV will allow effective prevention and control strategies to be designed for the benefit of PLWH.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [1] Genotypic resistance in HIV-1 infected patients with persistent low-level viremia
    Parra-Ruiz, Jorge
    Alvarez, Marta
    Chueca, Natalia
    Pena, Alejandro
    Pasquau, Juan
    Angel Lopez-Ruz, Miguel
    del Carmen Maroto, Maria
    Hernandez-Quero, Jose
    Garcia, Federico
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (02): : 75 - 80
  • [2] Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
    Hofstra, Laura Marije
    Mudrikova, Tania
    Stam, Arjen J.
    Otto, Sigrid
    Tesselaar, Kiki
    Nijhuis, Monique
    Wensing, Annemarie M. J.
    PLOS ONE, 2014, 9 (10):
  • [3] HIV-1 genetics of intermittent low-level viremia
    Tobin, NH
    Wang, Y
    Learn, GH
    McKernan, JL
    Ellis, GM
    Mohan, KM
    Holte, SE
    Pawluk, DM
    Melvin, AJ
    Lewis, PL
    Heath, LM
    Beck, IA
    Naugler, WE
    Mullins, JI
    Frenkel, LM
    PEDIATRIC RESEARCH, 2003, 53 (04) : 331A - 331A
  • [4] Laboratory Report of HIV-1 Low-Level Viremia
    Alvarez, Hortensia
    Llibre, Josep M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (02):
  • [5] Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients
    Vandenhende, Marie-Anne
    Ingle, Suzanne
    May, Margaret
    Chene, Genevieve
    Zangerle, Robert
    Van Sighem, Ard
    Gill, M. John
    Schwarze-Zander, Carolynne
    Hernandez-Novoa, Beatriz
    Obel, Niels
    Kirk, Ole
    Abgrall, Sophie
    Guest, Jodie
    Samji, Hasina
    Monforte, Antonella D'Arminio
    Llibre, Josep M.
    Smith, Colette
    Cavassini, Matthias
    Burkholder, Greer A.
    Shepherd, Bryan
    Crane, Heidi M.
    Sterne, Jonathan
    Morlat, Philippe
    AIDS, 2015, 29 (03) : 373 - 383
  • [6] HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
    Widera, Marek
    Dirks, Miriam
    Bleekmann, Barbara
    Jablonka, Robert
    Daeumer, Martin
    Walter, Hauke
    Ehret, Robert
    Verheyen, Jens
    Esser, Stefan
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2017, 206 (03) : 203 - 215
  • [7] HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
    Marek Widera
    Miriam Dirks
    Barbara Bleekmann
    Robert Jablonka
    Martin Däumer
    Hauke Walter
    Robert Ehret
    Jens Verheyen
    Stefan Esser
    Medical Microbiology and Immunology, 2017, 206 : 203 - 215
  • [8] Antiretroviral Drug Resistance in HIV-1-Infected Patients with Low-Level Viremia
    Mackie, Nicola E.
    Phillips, Andrew N.
    Kaye, Steve
    Booth, Clare
    Geretti, Anna-Maria
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (09): : 1303 - 1307
  • [9] Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients
    Ryscavage, Patrick
    Kelly, Sean
    Li, Jonathan Z.
    Harrigan, P. Richard
    Taiwo, Babafemi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3585 - 3598
  • [10] Analysis of virologic outcome in low-level HIV-1 viremia patients in a small cohort
    Ding, Lisha
    Chen, Xi
    He, Jianmei
    Zheng, Jun
    Wei, Xiuqing
    Qin, Biyun
    Li, Xiangzhong
    FUTURE VIROLOGY, 2022, 17 (09) : 627 - 632